Inuvo Posts Record Q1 2025 Revenue of $26.7M, up 57% Year-Over-Year

Stock Information for Asterias Biotherapeutics Inc. Common Series A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Asterias Biotherapeutics Inc. Common Series A

Inuvo to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24-25, 2025
Inuvo Reaffirms 25% Q2 YOY Growth Guidance and Completes 1:10 Reverse Stock Split
Inuvo to Present at Ladenburg Thalmann Technology Innovation Expo on May 21
Inuvo to Host First Quarter 2025 Financial Results Conference Call on Friday, May 9th at 8:30 A.M. ET
Inuvo to Present at the 15th Annual LD Micro Invitational on April 10th
Inuvo, Inc. Announces Charles D. Morgan's Retirement; Rob Buchner Joins Board
Inuvo Reports Record Fourth Quarter 2024 Revenue of $26.2 Million, 26% Year-Over-Year Growth and Net Income
Inuvo to Host Fourth Quarter and Year End 2024 Financial Results Conference Call on Thursday, February 27th at 4:15 P.M. EST

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.